MARKSANS.NS
Price:
$183.97
Market Cap:
$83.37B
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Phar...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2002-07-19
Stock Exchange
NSE
Ticker
MARKSANS.NS
According to Marksans Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is 23.71. This represents a change of -26.79% compared to the average of 32.39 of the last 4 quarters.
The mean historical PE Ratio of Marksans Pharma Limited over the last ten years is 36.57. The current 23.71 PE Ratio has changed 6.38% with respect to the historical average. Over the past ten years (40 quarters), MARKSANS.NS's PE Ratio was at its highest in in the September 2016 quarter at 1.09K. The PE Ratio was at its lowest in in the March 2017 quarter at -152.20.
Average
36.57
Median
18.02
Minimum
4.71
Maximum
202.75
Discovering the peaks and valleys of Marksans Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 739.95%
Maximum Annual PE Ratio = 202.75
Minimum Annual Increase = -79.28%
Minimum Annual PE Ratio = 4.71
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 26.42 | 15.73% |
| 2024 | 22.83 | 107.92% |
| 2023 | 10.98 | 8.83% |
| 2022 | 10.09 | 17.73% |
| 2021 | 8.57 | 81.91% |
| 2020 | 4.71 | -64.32% |
| 2019 | 13.20 | -68.56% |
| 2018 | 42.00 | -79.28% |
| 2017 | 202.75 | 739.95% |
| 2016 | 24.14 | 4.22% |
The current PE Ratio of Marksans Pharma Limited (MARKSANS.NS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
20.08
5-year avg
15.78
10-year avg
36.57
Marksans Pharma Limited’s PE Ratio is greater than Strides Pharma Science Limited (20.43), greater than Strides Pharma Science Limited (20.43), less than Aarti Pharmalabs Limited (24.55), less than Aarti Pharmalabs Limited (24.55), less than Sanofi India Limited (30.10), less than Sanofi India Limited (30.10), less than FDC Limited (29.78), less than FDC Limited (29.78), less than Yatharth Hospital & Trauma Care Services Limited (46.57), less than Yatharth Hospital & Trauma Care Services Limited (46.57),
| Company | PE Ratio | Market cap |
|---|---|---|
| 20.43 | $80.99B | |
| 20.43 | $81.17B | |
| 24.55 | $65.45B | |
| 24.55 | $65.41B | |
| 30.10 | $99.82B | |
| 30.10 | $99.73B | |
| 29.78 | $67.41B | |
| 29.78 | $67.51B | |
| 46.57 | $66.19B | |
| 46.57 | $66.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marksans Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Marksans Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Marksans Pharma Limited's PE Ratio?
How is the PE Ratio calculated for Marksans Pharma Limited (MARKSANS.NS)?
What is the highest PE Ratio for Marksans Pharma Limited (MARKSANS.NS)?
What is the 3-year average PE Ratio for Marksans Pharma Limited (MARKSANS.NS)?
What is the 5-year average PE Ratio for Marksans Pharma Limited (MARKSANS.NS)?
How does the current PE Ratio for Marksans Pharma Limited (MARKSANS.NS) compare to its historical average?